Bayer glyphosate lawsuit gains U.S. government support, aiming to significantly curb litigation risks by the end of 2026

Bayer responded to this by stating that the Deputy Attorney General's position aligns with the company's core legal argument regarding the "federal law's priority application" and that they are looking forward to the Supreme Court taking up the case. Currently, the Federal Circuit Court of Appeals is divided on the key legal question of "whether federal law takes precedence over state-based claims regarding product warning defects," and the Supreme Court's intervention is seen as helpful in establishing a uniform standard. Bayer CEO Bill Anderson emphasized in a statement: "This progress brings a positive signal for American farmers seeking regulatory certainty. If the authority of the federal pesticide label law cannot be maintained, it will ultimately harm farmers' access to important agricultural tools and have a long-term impact on investment and innovation in the related fields." Legal experts pointed out that the focus of this case is on the preemptive effect of the Federal ...